An industry team led by General Dynamics' (NYSE: GD) information technology business will help the Department of Defense implement cloud-based communication and collaboration applications under a potential 10-year, $4.4B blanket purchase agreement. The General Services Administration and DoD re-awarded the Defense Enterprise Office Solutions co...
L3Harris Technologies (NYSE: LHX) has secured a five-year, $97.5M contract from the U.S. Air Force to manage electronic warfare module repairs and returns for eight foreign military sales customers....
Global professional services firm EY has won a potential five-year, $263.4M from the Defense Finance and Accounting Service to help audit the U.S. Navy's financial statements....
Lockheed Martin’s (NYSE: LMT) rotary and mission systems business has received a potential $724M contract from the Missile Defense Agency to provide lifecycle engineering and development support for the Aegis ballistic missile defense system....
Hologic has secured a $119M contract to increase production capacity for diagnostic kits and test consumables in support of government efforts to sustain the U.S. industrial base through the coronavirus pandemic....
Raytheon Technologies has secured a potential 10-year, $192M contract to help the U.S. Air Force conduct system development tests on the Advanced Medium Range Air-to-Air Missile system....
AstraZeneca will supply 200 doses of the coronavirus vaccine candidate AZD1222 to the U.S. Army under a $286.9M firm-fixed-price contract....
Q.E.D. Systems has secured a potential three-year, $229.4M contract to help the U.S. Navy develop specifications and implement an availability strategy for multiple naval ship types....
The Defense Information Systems Agency has released a request for information on development and engineering requirements to support the establishment of an enterprise public safety communications network....
Eli Lilly and Co. (NYSE: LLY) has received a potential $375M contract from the departments of Defense and Health and Human Services to initially supply 300K doses of bamlanivimab, an investigational monoclonal antibody drug for COVID-19....
